The company estimated there are 25,000 such patients a year.

The company would not estimate how many come from California.

The company estimated the value of this plan at up to $100 million.

That is at the low end of the $1.50 to $1.60 range the company had estimated.

The company estimates that its shows have been seen by 3.5 million people throughout the world.

But the company estimates that only about 60,000 people are using one of the drugs.

As a result, the company can estimate how much a campaign is spending.

The company estimated that sales would be up 40 percent for the year over all.

The company did not estimate the size of the expected loss.

The company had estimated sales would grow by 5 percent.